Medicure Inc.
1200 Waverley Street
Suite 4
Winnipeg
Manitoba
R3T 0P4
Canada
Tel: 204-487-7412 or 888-435-2220
Fax: 204-488-9823
Website: http://www.medicureinc.com/
Email: info@medicureinc.com
198 articles with Medicure Inc.
-
Medicure Q2 Results and Conference Call Dates
8/3/2017
-
Medicure Closes Acquisition Of Additional Interests In Apicore LLC
7/13/2017
-
Medicure Provides Update On Apicore LLC Purchase Option
7/5/2017
-
Medicure Reports Financial Results For Quarter Ended March 31, 2017
5/25/2017
-
Medicure Q1 Results And Conference Call Dates
5/19/2017
-
Medicure Reports Financial Results For Quarter And Year Ended December 31, 2016
4/27/2017
-
Medicure To Announce Fiscal Year End 2016 Financial Results On April 26, 2017
3/29/2017
-
Medicure Announces FDA Approval For Apicore LLC's Generic Tetrabenazine
3/23/2017
-
Medicure Provides Apicore Secured Loan To Replace Knight Therapeutics Loan
1/9/2017
-
Medicure Closes Acquisition Of Majority Interest In Apicore LLC
12/1/2016
-
Medicure Exercises Option To Acquire Majority Interest In Apicore LLC
11/18/2016
-
Medicure Reports Third Quarter 2016 Financial Results
11/11/2016
-
Medicure To Announce Q3 2016 Financial Results On November 9, 2016
11/3/2016
-
Medicure Release: FDA Approves New AGGRASTAT Product Format
9/1/2016
-
Medicure Reports Second Quarter 2016 Financial Results
8/11/2016
-
Medicure Receives Response Letter From FDA On AGGRASTAT sNDA For New Indication
7/8/2016
-
Medicure Files Application For New AGGRASTAT Product Format
5/11/2016
-
Medicure COO Terminated, Effective Immediately
5/10/2016
-
Medicure Inc. Announces Upcoming Conference Presentations
4/5/2016
-
Medicure Inc. Reports Financial Results For Quarter And Year Ended December 31, 2015
3/31/2016